ManuelManders

Staff Attorney

阿姆斯特丹 + 31.20.305.4226

聯絡

*Share

Manuel Manders is a seasoned fund and investment management lawyer with more than 20 years of experience. He has advised on legal, tax, and regulatory matters regarding fund formation, fund reviews, fund M&A, investment joint ventures, and investment and management.

Manuel has advised a broad range of fund managers and investors in all mainstream investment types, as well as alternative investment categories such as private equity, venture capital, real estate, hedge funds, commodity, credit opportunity, mezzanine debt, renewable energy, and infrastructure funds.

執業經驗

  • Beaureale advised on post-establishment fundraising on cross border basis of Dutch fund structureJones Day is advising Beaureale on the post-establishment fundraising in the Netherlands, Germany, France and Belgium of a Dutch fund structure, to be managed on a cross border basis by Beaureale Group's French AIFM.
  • Climate Fund Managers forms Climate Investor ThreeJones Day advised Climate Fund Managers on the formation of Climate Investor Three, a funding platform for the purpose of investing in energy transition infrastructure companies in the green hydrogen value chain.
  • Gilde Healthcare VI raises €740 millionJones Day represented Gilde Healthcare in connection with the establishment of Gilde Healthcare Venture & Growth VI with €740 million in commitments.
  • IceLake Capital Management B.V. closes IceLake Capital Fund IIJones Day advised IceLake Capital Management B.V. on the fundraising of its second private equity fund, IceLake Capital Fund II, an investment fund for the purpose of investing in small- and medium-sized companies with sustainable competitive advantages and solid growth prospects, with a general focus on the business services and software sectors in the Benelux, closing at €315 million.
  • Gilde Healthcare establishes Gilde Healthcare Private Equity IVJones Day advised Gilde Healthcare Partners B.V. in the establishment of Gilde Healthcare Private Equity IV, a private equity fund that invests in profitable healthcare companies operating in the lower mid-market in North-west Europe.
  • Cygnum Capital extends AIFMD licenseJones Day advised Cygnum Capital on the extension of Cygnum Capital's AIFMD license in order to manage public debt funds/feeder AIFs in private and/or public debt.
  • Climate Fund Managers announces first close of CI2, its second global climate fund, at $675 millionJones Day represented Climate Fund Managers (CFM) with the structuring, establishment, fund raising and first closing of the new fund, CI2 Construction Equity Fund, that invests in water, sanitation and oceans infrastructure projects in Africa, South and South East Asia, and Latin America.
  • DM Capital completes fundraising of Dutch Mezzanine Fund IIIJones Day advised DM Capital B.V. on the structuring and fundraising of Dutch Mezzanine Fund III, a debt fund primarily investing in mezzanine and other private subordinated debt and uni-tranche investments.
  • Rabo Fund Management continues fundraising of EUR multi-billion mortgage loan platformJones Day is advising Rabo Fund Management on the continued fundraising of its EUR multi-billion mortgage loan platform and the structuring of the Rabo Dutch Mortgages Fund Yellow.
  • BPD Europe B.V. applies for AIFM license for BPD RCF Fundmanagement B.V. and has set up BPD WoningfondsJones Day advised BPD Europe B.V., a subsidiary of Coöperatieve Rabobank U.A., on the AIFM license application for BPD RCF Fundmanagement B.V. and the establishment of BPD Woningfonds, a real estate fund focusing on the acquisition of affordable and sustainable rental homes for mid-level incomes.
  • CBRE Global Investment Partners acquires 6,458-unit portfolio of Spanish residential properties for €870 millionJones Day advised CBRE Global Investment Partners in connection with its acquisition of a 6,458-unit portfolio of Spanish residential properties valued at €870 million.
    •

    *Before sending, please note:

    *Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.